Subscribe to RSS - ResMed


ResMed details progress on new CEO, initiates dividend


SAN DIEGO – Dr. Pete Farrell will remain CEO of ResMed until the end of the calendar year 2013, per the request of the manufacturer’s board of directors.

In the meantime, ResMed will continue to evaluate potential internal CEO candidates.

Invacare briefs shareholders on FDA, earnings

Also: ResMed reports double-digit growth

ELYRIA, Ohio – Invacare expects to engage a third-party to audit its compliance with U.S. Food and Drug Administration (FDA) regulations in the fourth quarter of this year, company officials said during a conference call this week to discuss first quarter earnings.

Miss ResMed's earnings conference call yesterday? I didn't!

Friday, January 27, 2012

We don't always have the time (or, honestly, the wherewithal) to listen to every earnings conference call by every public company in the HME industry. But when we do, it's almost always worthwhile.

Joe Lewarski knows how to keep a secret; Invacare reaches out to clinical and academic communities

Thursday, March 25, 2010

I had a long conversation with Joe Lewarski yesterday on how important it is for respiratory therapists to titrate patients to their oxygen delivery equipment—both conservers and concentrators.

CPAP providers enter 'brave new world'


Its effect has essentially changed the way HME companies do business, with some exiting the Medicare program and others modifying their approaches in various ways.

Report from Invacare Media Day: The world could be passing us by

Wednesday, August 5, 2009

Invacare officials worry that the HME industry may be blowing its chance at reforming the oxygen benefit by failing to speak with a common voice.